107 related articles for article (PubMed ID: 20124470)
1. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW
Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470
[TBL] [Abstract][Full Text] [Related]
2. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression.
Li LB; Louie MC; Chen HW; Zou JX
Cancer Lett; 2008 Mar; 261(1):64-73. PubMed ID: 18162290
[TBL] [Abstract][Full Text] [Related]
4. The roles and action mechanisms of p160/SRC coactivators and the ANCCA coregulator in cancer.
Hsia EY; Zou JX; Chen HW
Prog Mol Biol Transl Sci; 2009; 87():261-98. PubMed ID: 20374707
[TBL] [Abstract][Full Text] [Related]
5. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
6. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.
Louie MC; Zou JX; Rabinovich A; Chen HW
Mol Cell Biol; 2004 Jun; 24(12):5157-71. PubMed ID: 15169882
[TBL] [Abstract][Full Text] [Related]
7. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
[TBL] [Abstract][Full Text] [Related]
9. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H
Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507
[TBL] [Abstract][Full Text] [Related]
10. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
12. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity.
Louie MC; Revenko AS; Zou JX; Yao J; Chen HW
Mol Cell Biol; 2006 May; 26(10):3810-23. PubMed ID: 16648476
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.
Dong Y; Asch HL; Ying A; Asch BB
Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462
[TBL] [Abstract][Full Text] [Related]
14. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
15. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.
Zou JX; Revenko AS; Li LB; Gemo AT; Chen HW
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18067-72. PubMed ID: 17998543
[TBL] [Abstract][Full Text] [Related]
16. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
Kuang SQ; Liao L; Wang S; Medina D; O'Malley BW; Xu J
Cancer Res; 2005 Sep; 65(17):7993-8002. PubMed ID: 16140972
[TBL] [Abstract][Full Text] [Related]
17. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy.
Eelen G; Vanden Bempt I; Verlinden L; Drijkoningen M; Smeets A; Neven P; Christiaens MR; Marchal K; Bouillon R; Verstuyf A
Oncogene; 2008 Jul; 27(30):4233-41. PubMed ID: 18345034
[TBL] [Abstract][Full Text] [Related]
18. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.
Zou JX; Duan Z; Wang J; Sokolov A; Xu J; Chen CZ; Li JJ; Chen HW
Mol Cancer Res; 2014 Apr; 12(4):539-49. PubMed ID: 24391143
[TBL] [Abstract][Full Text] [Related]
19. [Expression of AIB1 protein in gynecological tumors].
Han XY; Zhang XM; Chen Y; Yang KX; Qie MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):246-9. PubMed ID: 17441340
[TBL] [Abstract][Full Text] [Related]
20. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways.
Ru Lee W; Chen CC; Liu S; Safe S
J Cell Biochem; 2006 Sep; 99(1):209-20. PubMed ID: 16598773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]